Company Analysis

Rocket Pharmaceuticals, Inc. (RCKT)

Nasdaq: RCKT · Pharmaceutical Preparations · New York, NY · filing with the SEC since 2004
Grade4.5
◀ Past 5.4● Present 5.0▶ Future 3.6
4 est.

Filings

342 filings since 2017 beside 455 insider forms · Non-accelerated filer and smaller reporting company · read from EDGAR on Nov 13, 2026
Due nextNon-accelerated filer and smaller reporting company
10-K Annual report for the fiscal year ending Dec 31, 2026Non-accelerated filers and smaller reporting companies have 90 days after the fiscal year ends. by Mar 31, 2027
10-Q Quarterly report for the quarter ending Mar 31, 2027Non-accelerated filers and smaller reporting companies have 45 days after the quarter ends; quarter ends are taken to the month end. by May 15, 2027

A deadline is the latest date the SEC's rules allow for its filer category. It is not a forecast of the day the company files. Last time, the results release (8-K item 2.02) came 43 days after the quarter ended. The proxy statement was last filed Apr 6, 2026.

Filings a yearinsider forms included
4645566699112135107
20192020202120222023202420252026

2026 counts to Nov 13, 2026.

Officer or director change (8-K item 5.02): 14 times in the last 36 months, the newest Aug 27, 2026.SEC letters: 2 in the last 36 months, the newest Mar 6, 2026.
Insider forms 455

Insider forms (3, 4, 5 and 144) are counted each year but not listed here; the people and their trades are on the Ownership tab.

FiledFormWhat it is, in plain wordsPeriodAsk
Nov 12, 2026 10-Q Quarterly report Sep 30, 2026
Nov 12, 2026 8-K items 2.02, 9.01 Results released · Current report
Oct 30, 2026 SCHEDULE 13G/A Large holder update, amended
Oct 6, 2026 8-K items 1.01, 2.03, 3.02, 7.01, 9.01 Major agreement signed; New debt or obligation taken on; Shares sold without registration; Investor disclosure (Regulation FD) · Current report Sep 30, 2026
Sep 15, 2026 8-K items 7.01, 9.01 Investor disclosure (Regulation FD) · Current report
Sep 2, 2026 25-NSE Delisting notice from the exchange
Aug 27, 2026 8-K item 5.02 Officer or director change · Current report Aug 21, 2026
Aug 10, 2026 10-Q Quarterly report Jun 30, 2026
Aug 10, 2026 8-K items 2.02, 9.01 Results released · Current report
Aug 3, 2026 8-K items 7.01, 9.01 Investor disclosure (Regulation FD) · Current report
Jul 31, 2026 SCHEDULE 13G Large holder notice
Jul 14, 2026 S-8 Employee stock plan registration
Jun 30, 2026 8-K item 5.02 Officer or director change · Current report Jun 24, 2026
Jun 12, 2026 8-K items 2.01, 7.01, 9.01 Purchase or sale of a business completed; Investor disclosure (Regulation FD) · Current report Jun 10, 2026
May 28, 2026 SC TO-I/A Issuer tender offer, amended
May 21, 2026 8-K item 5.07 Shareholder vote · Current report May 20, 2026
May 7, 2026 10-Q Quarterly report Mar 31, 2026
May 7, 2026 8-K items 2.02, 9.01 Results released · Current report
Apr 28, 2026 8-K items 1.01, 7.01, 9.01 Major agreement signed; Investor disclosure (Regulation FD) · Current report Apr 26, 2026
Apr 27, 2026 SC TO-I Issuer tender offer
Apr 6, 2026 ARS Annual report to shareholders Dec 31, 2025
Apr 6, 2026 DEFA14A Extra proxy material
Apr 6, 2026 DEF 14A Proxy statement May 20, 2026
Apr 3, 2026 SC TO-C Tender offer communication
Mar 27, 2026 8-K items 7.01, 9.01 Investor disclosure (Regulation FD) · Current report Mar 26, 2026
Mar 27, 2026 SCHEDULE 13G/A Large holder update, amended
Mar 25, 2026 PRE 14A Preliminary proxy statement May 20, 2026
Mar 10, 2026 EFFECT Registration effective
Mar 10, 2026 8-K items 1.01, 1.02, 9.01 Major agreement signed; Major agreement ended · Current report
Mar 10, 2026 424B5 Shelf offering
Mar 6, 2026 CORRESP Reply to the SEC
Mar 6, 2026 UPLOAD SEC comment letter
Mar 2, 2026 S-3 Shelf registration
Feb 26, 2026 10-K Annual report Dec 31, 2025
Feb 26, 2026 8-K items 2.02, 9.01 Results released · Current report
Feb 13, 2026 SCHEDULE 13G/A Large holder update, amended
Jan 30, 2026 SCHEDULE 13G/A Large holder update, amended
Nov 6, 2025 10-Q Quarterly report Sep 30, 2025
Nov 6, 2025 8-K items 2.02, 9.01 Results released · Current report
Oct 14, 2025 8-K items 8.01, 9.01 Other event · Current report
40 of 342 shown

Every row opens the filing on EDGAR. The plain words are the site's own for each form and each 8-K item; the complete history, insider forms included, is on EDGAR.

SI Assistanton RCKT · research, not advice